Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market
Aurora Cannabis Q4 sales rose 34% to $63.07 million, led by medical cannabis and plant propagation, despite missing earnings estimates.
Deadline missed- Marijuana market reform could come back during veto session with hemp regulations
Canadian Indigenous leader says he was ‘filled with rage’ before ‘intense’ conversation with Trump US aircraft carrier USS George Washington counters China navy presence Singer performs US national …
Why Curaleaf Stock Blasted Almost 5% Higher Today
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium …
Marijuana industry debt crisis intensifies as lenders circle overleveraged operators
An overleveraged marijuana operator is resorting to what observers say are increasingly creative and desperate methods to avoid liquidation.
Why Curaleaf Stock Was a Winner on Wednesday
And that would be a fine development for Curaleaf and the rest of the ever-struggling marijuana industry. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Cannabis stocks jump as Trump confirms marijuana rescheduling move (update)
Shares of Canadian cannabis companies extended premarket gains on Monday after President Donald Trump said that he is considering a proposal to reschedule marijuana as a less dangerous drug under the …
While Investors Chase Monday’s Tilray, Canopy And Aurora Rally, A Potential Federal Shift Could Redefine Cannabis Growth Fundamentals
Shares of major cannabis companies are trading higher Monday morning. The stocks are soaring following a WSJ report that President Trump is considering reclassifying marijuana as a less dangerous drug …
Cannabis Stocks Rally as Trump Mulls Marijuana Reclassification
Shares of Canopy Growth Corp (NASDAQ:CGC) jumped 19.2% on Monday amid reports that President Donald Trump is considering lowering marijuana’s federal classification, a move that could reshape the …
Cannabis stocks rally after Trump says he is weighing drug reclassification
Cannabis stocks rallied after President Donald Trump said he might reclassify marijuana as having a lower danger level. Such a move would be “a game changer” for the industry, one money manager said.
Is Small-Cap Corbus Pharma a Worthy Cannabis Investment?
Corbus Pharmaceuticals CRBP is not your typical cannabis stock involved in cultivation, processing, or sales of marijuana products. Instead, this clinical-stage company is focused on developing …
Hedge Fund Veteran Doug Kass Says Most Cannabis Stocks Are … – Benzinga
Four Marijuana Stocks Worth Watching. Despite his bearish view of the broader market, Kass said a select few companies remain attractive, particularly for long-term investors with patience.
To Save America’s Youth, Lawmakers Should Invest in Drug Prevention | Opinion
To maximize their effectiveness, drug prevention programs must reach adolescents before they are exposed to substance use in their peer groups.
After court ruling, APD says it won’t cite people for small amounts of marijuana — for now
When an appeals court struck down Austin’s marijuana decriminalization ordinance late last month, confusion and disappointment flooded social media. “So am I a criminal now?” Reddit user Environmental …
7 Best Marijuana Stocks and ETFs to Buy in 2025 – U.S. News
Marijuana Stocks and ETFs. Investing. Money. Home. 7 Best Marijuana Stocks and ETFs to Buy in 2025. In this long-suffering industry, investors continue looking for federal reform. By Matt Whittaker | …
Recent Comments